Since no other drug in the market offers proven cardiac benefits along with weight loss (including Eli Lillys), it is safe to say that Novo Nordisk is way ahead in the race and will dominate the market for the foreseeable future
The debate over some GLP-1 alternatives was resolved when Novo Nordisk, maker of Ozempic and Wegovy, recently struck a deal with popular telehealth platform Hims & Hers to sell Ozempic injections and Wegovy injections and tablets at the same price (no increase)
All you need to do is take a shot
Like I would rather see you have, you know, more body fat to a point, right
The mechanism of action involves several physiological processes: Enhanced insulin secretion : They stimulate glucose-dependent insulin release from pancreatic beta cells, which helps lower blood glucose levels without causing hypoglycaemia when glucose levels are normal Suppressed glucagon secretion : They reduce inappropriate glucagon release from pancreatic alpha cells, further improving glycaemic control Delayed gastric emptying : They slow the rate at which food leaves the stomach, promoting satiety and reducing postprandial glucose excursions
Gastroenterology 142:4654.e42
